Cointime

Viracor-IBT Laboratories

company

About

Viracor-IBT Laboratories is dedicated to being the leading specialty diagnostics laboratory partner in allergy, immunology, and infectious

  • 251 - 500

Highlights

Total Funding Amount
$29.75M
Funding Rounds
4
Investors
3

Details

Last Funding Type
Series B
Last Funding Money Raised
$3.51M
Industries
Biotechnology,Health Care,Health Diagnostics,Information Technology,Life Science,Medical
Founded date
Jan 1, 2000
Number Of Employee
251 - 500
Operating Status
Active

Viracor-IBT Laboratories is dedicated to being the leading specialty diagnostics laboratory partner in allergy, immunology, and infectious disease testing.

They provide doctors and hospitals the tests, results and support they need to deliver the best care possible, and they collaborate with pharmaceutical researchers to solve difficult problems and accelerate drug development.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$29.75M
Viracor-IBT Laboratories has raised a total of $29.75M in funding over 2 rounds. Their latest funding was raised on Mar 7, 2007 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 7, 2007 Series C $20.50M 1 Channel Medical Partners — Detail
Jul 20, 2004 Series B $3.30M 2 — — Detail
Mar 1, 2004 Series B $3.51M 2 — — Detail
Jun 4, 2002 Series A $2.44M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Viracor-IBT Laboratories is funded by 3 investors. Channel Medical Partners and Early Stage Enterprises are the most recent investors.
Investor Name Lead Investor Funding Round
Channel Medical Partners Yes Series C
Early Stage Enterprises — Series B
Maryland Department of Business and Economic Development — Series B
Cointime
เนื้อหา
บริษัท